Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...